• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The use of ultrasound in schistosomiasis.

作者信息

Hatz C F

机构信息

Department of Medicine and Diagnostics, Swiss Tropical Institute, Basel, Switzerland.

出版信息

Adv Parasitol. 2001;48:225-84. doi: 10.1016/s0065-308x(01)48007-9.

DOI:10.1016/s0065-308x(01)48007-9
PMID:11013757
Abstract

Ultrasound was introduced in the 1970s as a method to detect schistosomal pathology both at hospital and field level. It has since been established as a safe, rapid, non-invasive and relatively inexpensive technique for assessing schistosomiasis-related lesions in individual patients and in community surveys. It can be used to validate laboratory tests to measure morbidity and provides an opportunity to visualize the evolution of pathological lesions after treatment. The interpretation of ultrasound imaging depends on the experience of the investigators and it may not be the ideal tool to detect early lesions of the affected organs. This paper reviews and critically discusses the present knowledge of morbidity due to the different types of schistosomiasis as it can be observed using ultrasound, with special reference to its use as a diagnostic and monitoring tool in field surveys. It analyses the practical use, benefits and drawbacks of ultrasound investigations to assess pathological lesions due to schistosomiasis in relation to other diagnostic tools. The role of ultrasound investigations among other monitoring approaches in control programmes is discussed in the context of rational control strategies.

摘要

相似文献

1
The use of ultrasound in schistosomiasis.
Adv Parasitol. 2001;48:225-84. doi: 10.1016/s0065-308x(01)48007-9.
2
Treatment and re-treatment strategies for schistosomiasis control in different epidemiological settings: a review of 10 years' experiences.不同流行背景下控制血吸虫病的治疗与再治疗策略:十年经验回顾
Acta Trop. 2003 May;86(2-3):243-54. doi: 10.1016/s0001-706x(03)00045-7.
3
The impact of chemotherapy on morbidity due to schistosomiasis.化疗对血吸虫病所致发病率的影响。
Acta Trop. 2003 May;86(2-3):161-83. doi: 10.1016/s0001-706x(03)00032-9.
4
Dynamic aspects of morbidity and acquired immunity in schistosomiasis control.血吸虫病控制中发病率及获得性免疫的动态变化
Acta Trop. 1996 Oct;62(2):105-17. doi: 10.1016/s0001-706x(96)00039-3.
5
Evolution of schistosomiasis-induced pathology after therapy and interruption of exposure to schistosomes: a review of ultrasonographic studies.治疗后及停止接触血吸虫后血吸虫病所致病理变化的演变:超声研究综述
Acta Trop. 2000 Oct 23;77(1):111-31. doi: 10.1016/s0001-706x(00)00125-x.
6
Schistosomiasis.血吸虫病
Adv Exp Med Biol. 2014;766:47-75. doi: 10.1007/978-1-4939-0915-5_3.
7
Schistosomiasis: challenges for control, treatment and drug resistance.血吸虫病:控制、治疗及耐药性方面的挑战
Curr Opin Infect Dis. 2006 Dec;19(6):577-82. doi: 10.1097/01.qco.0000247591.13671.6a.
8
Ultrasound in schistosomiasis--a critical look at methodological issues and potential applications.血吸虫病中的超声检查——对方法学问题和潜在应用的批判性审视
Acta Trop. 1992 May;51(1):89-97. doi: 10.1016/0001-706x(92)90023-q.
9
"Control of schistosomiasis": morbidity-reduction and chemotherapy.“血吸虫病的控制”:发病率降低与化疗
Acta Leiden. 1982;49:101-111.
10
Measurement of schistosomiasis-related morbidity at community level in areas of different endemicity.在不同流行程度地区的社区层面测量血吸虫病相关发病率。
Bull World Health Organ. 1990;68(6):777-87.

引用本文的文献

1
The Basel ultrasonography protocol for assessing hepatosplenic pathologies in Asian schistosomiasis: report of a WHO expert meeting.用于评估亚洲血吸虫病肝脾病变的巴塞尔超声检查方案:世卫组织专家会议报告
Infect Dis Poverty. 2025 Aug 8;14(1):83. doi: 10.1186/s40249-025-01349-x.
2
IRF4 regulates myeloid-derived suppressor cells expansion and function in Schistosoma japonicum-infected mice.IRF4 调节日本血吸虫感染小鼠中髓源性抑制细胞的扩增和功能。
Parasit Vectors. 2024 Nov 28;17(1):492. doi: 10.1186/s13071-024-06543-8.
3
Diagnosis of Human Trematode Infections.
人体吸虫感染的诊断。
Adv Exp Med Biol. 2024;1454:541-582. doi: 10.1007/978-3-031-60121-7_14.
4
Antimalarial artesunate-mefloquine versus praziquantel in African children with schistosomiasis: an open-label, randomized controlled trial.青蒿琥酯-甲氟喹与吡喹酮治疗非洲血吸虫病儿童:一项开放标签、随机对照试验。
Nat Med. 2024 Jan;30(1):130-137. doi: 10.1038/s41591-023-02719-4. Epub 2024 Jan 4.
5
Ultrasound aspects and risk factors associated with urogenital schistosomiasis among primary school children in Mali.马里小学生泌尿生殖系统血吸虫病的超声表现及相关危险因素。
Infect Dis Poverty. 2023 Apr 20;12(1):40. doi: 10.1186/s40249-023-01071-6.
6
A 14-year follow-up of ultrasound-detected urinary tract pathology associated with urogenital schistosomiasis in women living in the Msambweni region of coastal Kenya.肯尼亚沿海姆桑布韦地区女性生殖泌尿系统血吸虫病相关的超声检测到的尿路病理的 14 年随访结果。
Trans R Soc Trop Med Hyg. 2023 Sep 1;117(9):637-644. doi: 10.1093/trstmh/trad020.
7
Urinary interleukins (IL)-6 and IL-10 in schoolchildren from an area with low prevalence of Schistosoma haematobium infections in coastal Kenya.肯尼亚沿海地区埃及血吸虫感染率较低地区学童尿液中的白细胞介素(IL)-6和IL-10
PLOS Glob Public Health. 2023 Apr 5;3(4):e0001726. doi: 10.1371/journal.pgph.0001726. eCollection 2023.
8
Defining elimination as a public health problem for schistosomiasis control programmes: beyond prevalence of heavy-intensity infections.将消除定义为血吸虫病控制规划中的公共卫生问题:超越重度感染的流行率。
Lancet Glob Health. 2022 Sep;10(9):e1355-e1359. doi: 10.1016/S2214-109X(22)00287-X.
9
Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children (SchistoSAM): protocol of a proof-of-concept, open-label, two-arm, individually-randomised controlled trial.青蒿琥酯-甲氟喹作为非洲儿童血吸虫病新型替代治疗方法的评估(SchistoSAM):一项概念验证、开放标签、双臂、个体随机对照试验方案
BMJ Open. 2021 Jun 24;11(6):e047147. doi: 10.1136/bmjopen-2020-047147.
10
Elimination of Schistosomiasis Mekongi from Endemic Areas in Cambodia and the Lao People's Democratic Republic: Current Status and Plans.柬埔寨和老挝人民民主共和国流行地区湄公血吸虫病的消除:现状与计划
Trop Med Infect Dis. 2019 Feb 7;4(1):30. doi: 10.3390/tropicalmed4010030.